Alopecia universalis during treatment with leflunomide and adalimumab - Case report
Rosana Lazzarini, Gabriela Cunha Capareli, Roberta Buense and 1 more
Anais Brasileiros de Dermatologia · 2014
doi:10.1590/abd1806-4841.20142944 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Alopecia areata is a non-scarring form of alopecia that can be localized or widespread. Its etiology is unknown, but immunological factors are implicated in its pathogenesis. With the more frequent use of anti TNFα biologic drugs, some alopecia areata cases during their use have been described. We report a case of universal alopecia in a patient with rheumatoid arthritis while using adalimumab and leflunomide.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.